Advertisement
UK markets closed
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • CRUDE OIL

    83.02
    +1.12 (+1.37%)
     
  • GOLD FUTURES

    2,342.60
    -3.80 (-0.16%)
     
  • DOW

    38,480.66
    +240.68 (+0.63%)
     
  • Bitcoin GBP

    53,603.60
    +469.70 (+0.88%)
     
  • CMC Crypto 200

    1,435.45
    +20.69 (+1.46%)
     
  • NASDAQ Composite

    15,677.94
    +226.63 (+1.47%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

Boston Scientific’s Valuations and Price Performance

Boston Scientific’s Valuations and Price Performance

Boston Scientific’s (BSX) enterprise value is $45.1 billion, and its enterprise-value-to-revenue ratio is 4.98x. The stock is trading at a forward PE multiple of 21.86x, which is expected to have a five-year growth multiple of 2.13x. Its price-to-sales ratio is 5.23x, and its price-to-book ratio is 6.72x. Its enterprise-value-to-EBITDA ratio is 18.5x.